Stryker Corporation SYK

Full chart Compare
Set alert

Price alert · SYK

All alert types
310.55 USD +3.74 (+1.22%)

At closeNov 3, 2026, 4:00 PM EST

310.55 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

306.41 Day range 312.61
267.00 52-week range 389.33
YTD
-11.64%
1 year
-13.29%
Market cap
118.22B
Revenue (ttm)
26.30B
Profit margin
13.78%
EPS (ttm)
9.39
Shares out
380.69M
P/E ratio
33.07
Forward P/E
19.04
Dividend
3.52 (1.15%)
Ex-dividend date
Sep 29, 2026
YTD return
-11.64%
1-year return
-13.29%
Volume
2.59M
Avg volume
2.70M
Open
307.12
Previous close
306.81
Day's range
306.41 – 312.61
52-week range
267.00 – 389.33
Beta
0.77
Analysts
Buy
Price target
340.48 (+9.6%)
Earnings date
Feb 4, 2027

6M +18.54 (+6.37%)

275300325350May 21Jun 29Aug 5Sep 10Oct 15309.42

Key statistics

Enterprise value
128.96B
PEG ratio
1.44
Price / sales
4.50
Price / book
5.04
Dividend yield
1.15%
Payout ratio
37.49%
Revenue growth
7.60%
Free cash flow
3.70B
Total cash
3.27B
Total debt
15.43B
Return on equity
16.02%
Short % of float
1.56%
50-day average
292.25
200-day average
323.54

Financials — quick view

All financials
SYK Revenue — quarterly 6.52B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
SYK Net income — quarterly 753.00M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
SYK EPS — quarterly 1.97
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

SYK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20265.04———
Oct 29, 2026Sep 30, 20263.553.52-0.03-0.85%
Jul 30, 2026Jun 30, 20263.493.69+0.20+5.73%
Apr 30, 2026Mar 31, 20262.982.60-0.38-12.75%
Jan 29, 2026Dec 31, 20254.404.47+0.07+1.59%
Oct 30, 2025Sep 30, 20253.133.19+0.06+1.92%

Upgrades / downgrades

SYK analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026Truist SecuritiesreitHoldHold
Nov 2, 2026StifelmainBuyBuy
Oct 30, 2026JP MorganmainOverweightOverweight
Oct 30, 2026CitigroupmainBuyBuy
Oct 30, 2026TD CowenmainHoldHold
Oct 30, 2026RBC CapitalmainOutperformOutperform

About Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
stryker.com

News

Your note

Sign in to keep a note on SYK — it syncs with the Stock Master app.

Insider holders

SYK insider holders
InsiderRelationLatest transactionDateShares held
BECKER YIN COfficerConversion of Exercise of derivative securityMar 20, 202536,052
CROTTY DYLAN BRAMOfficerSaleAug 20, 20260
FINK MARY KATHRYNOfficerSaleMay 10, 20260
GOLSTON ALLAN CDirectorSaleFeb 17, 202514,895
LOBO KEVIN AChief Executive OfficerConversion of Exercise of derivative securityMar 19, 2026222,952
MENON VIJU SOfficerConversion of Exercise of derivative securityMar 19, 202617,580

Institution ownership

SYK institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.20%27,414,7428.51BJun 29, 2026
Vanguard Capital Management LLC5.92%22,536,8437.00BJun 29, 2026
JPMORGAN CHASE & CO4.53%17,260,9435.36BJun 29, 2026
State Street Corporation4.08%15,532,5654.82BJun 29, 2026
Greenleaf Trust3.98%15,155,9334.71BSep 29, 2026
Price (T.Rowe) Associates Inc3.13%11,916,0573.70BJun 29, 2026

Fund ownership

SYK fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.88%10,952,9793.40BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.35%8,941,9262.78BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.22%4,650,7411.44BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.18%4,478,7341.39BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.13%4,318,8411.34BSep 29, 2026
SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF0.65%2,469,410766.92MSep 29, 2026